troloxoyl sh-pentapeptide-12 sp hamilelikte güvenli mi?

Related ingredients

Frequently asked questions

troloxoyl sh-pentapeptide-12 sp hamilelikte güvenli mi?

No harmonised CLP classification (ECHA Annex VI), no SCCS or CIR safety opinion located, and no peer-reviewed reproductive toxicity or human pregnancy data found for Troloxoyl SH‑pentapeptide‑12. As a peptide conjugate with no evidence of systemic reproductive toxicity, default scoring is 0 for hazard and mechanism; expected dermal absorption from topical cosmetic use is negligible (peptides are large/polar), so exposure scored 0. Sources checked: ECHA Annex VI (no entry), SCCS/CIR (no assessment), PubMed (no relevant reproductive studies), CosIng/PubChem (ingredient listing only).

troloxoyl sh-pentapeptide-12 sp emzirirken güvenli mi?

Same rationale as pregnancy: no harmonised classifications or authoritative safety assessments indicating reproductive or lactation risk; no data demonstrating mammary transfer or effects on lactation. Topical peptide conjugates are expected to have negligible systemic availability under normal cosmetic use.

troloxoyl sh-pentapeptide-12 sp bebek cildi için güvenli mi?

No infant-specific data were identified. Peptide conjugates are generally large molecules with low skin penetration, so exposure for babies (0–3 yr) is assessed as negligible in absence of absorption data. Per instruction, baby exposure was not increased because adult exposure is considered negligible and no data indicate measurable absorption.

VeriMom troloxoyl sh-pentapeptide-12 sp nasıl puanlıyor?

VeriMom troloxoyl sh-pentapeptide-12 sp'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.

Hamilelikte troloxoyl sh-pentapeptide-12 sp yerine neler kullanılabilir?

Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.